Indeed, Decr1 deficiency restored the impaired glucose and pyruvate oxidation rates observed in diabetic cardiomyocytes, suggesting that targeting Decr1 could normalize the metabolic disturbances characteristic of DCM. This evidence concerns the gene DECR1 and familial dilated cardiomyopathy.